Cure by cooling: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Cure by cooling
Largest movements
- Cash -€12,311
down €12,311 (-49.8%), from €24,699 to €12,388
mainly Net result for the year (-€9,850) and Trade debts (-€2,994)
- Stocks and contracts +€809
new in 2025: €809
- Reserves -€7,748
down €7,748 (-54.7%), from €14,157 to €6,408
- Trade debts -€2,994
down €2,994 (-94.1%), from €3,182 to €189
- Profit (loss) carried forward -€2,102
new in 2025: -€2,102
- Other debts +€1,030
up €1,030 (+20.7%), from €4,977 to €6,007
- Gross operating margin -€5,743
down €5,743 (-166%), from -€3,468 to -€9,211
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €40,917 | €29,102 | -€11,814 | -28.9% |
| Current assets | 29/58 | €40,917 | €29,102 | -€11,814 | -28.9% |
| Stocks and contracts in progress | 3 | - | €809 | +€809 | |
| Stocks | 30/36 | - | €809 | +€809 | |
| Amounts receivable within one year | 40/41 | €16,218 | €15,906 | -€312 | -1.9% |
| Trade receivables | 40 | €15,465 | €15,465 | = | 0.0% |
| Other amounts receivable | 41 | €753 | €441 | -€312 | -41.4% |
| Cash at bank and in hand | 54/58 | €24,699 | €12,388 | -€12,311 | -49.8% |
| Total equity and liabilities | 10/49 | €40,917 | €29,102 | -€11,814 | -28.9% |
| Equity | 10/15 | €32,757 | €22,907 | -€9,850 | -30.1% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €14,157 | €6,408 | -€7,748 | -54.7% |
| Distributable reserves | 133 | €14,157 | €6,408 | -€7,748 | -54.7% |
| Profit (loss) carried forward | 14 | - | -€2,102 | -€2,102 | |
| Amounts payable | 17/49 | €8,160 | €6,196 | -€1,964 | -24.1% |
| Amounts payable within one year | 42/48 | €8,160 | €6,196 | -€1,964 | -24.1% |
| Trade debts | 44 | €3,182 | €189 | -€2,994 | -94.1% |
| Suppliers | 440/4 | €3,182 | €189 | -€2,994 | -94.1% |
| Other amounts payable | 47/48 | €4,977 | €6,007 | +€1,030 | +20.7% |
| Other operating charges | 640/8 | €505 | €520 | +€14 | +2.8% |
| Gross operating margin | 9900 | -€3,468 | -€9,211 | -€5,743 | -166% |
| Operating profit (loss) | 9901 | -€3,973 | -€9,731 | -€5,757 | -145% |
| Financial income | 75/76B | €21 | €0 | -€21 | -97.7% |
| Recurring financial income | 75 | €21 | €0 | -€21 | -97.7% |
| Financial charges | 65/66B | €156 | €120 | -€37 | -23.6% |
| Recurring financial charges | 65 | €156 | €120 | -€37 | -23.6% |
| Profit (loss) for the period before taxes | 9903 | -€4,109 | -€9,850 | -€5,741 | -140% |
| Profit (loss) for the period | 9904 | -€4,109 | -€9,850 | -€5,741 | -140% |
| Profit (loss) for the period to be appropriated | 9905 | -€4,109 | -€9,850 | -€5,741 | -140% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.